iRhythm Technologies (IRTC) Competitors $169.79 +1.77 (+1.05%) Closing price 04:00 PM EasternExtended Trading$169.80 +0.00 (+0.00%) As of 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRTC vs. ZBH, SNN, SOLV, PEN, STVN, GKOS, BLCO, TMDX, SLNO, and NVSTShould you be buying iRhythm Technologies stock or one of its competitors? The main competitors of iRhythm Technologies include Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), and Envista (NVST). These companies are all part of the "medical equipment" industry. iRhythm Technologies vs. Its Competitors Zimmer Biomet Smith & Nephew SNATS Solventum Penumbra Stevanato Group Glaukos Bausch + Lomb TransMedics Group Soleno Therapeutics Envista iRhythm Technologies (NASDAQ:IRTC) and Zimmer Biomet (NYSE:ZBH) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, dividends, analyst recommendations, risk, profitability, media sentiment and institutional ownership. Which has more volatility & risk, IRTC or ZBH? iRhythm Technologies has a beta of 1.41, meaning that its share price is 41% more volatile than the S&P 500. Comparatively, Zimmer Biomet has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500. Do analysts prefer IRTC or ZBH? iRhythm Technologies currently has a consensus target price of $162.64, indicating a potential downside of 4.21%. Zimmer Biomet has a consensus target price of $111.44, indicating a potential upside of 4.28%. Given Zimmer Biomet's higher probable upside, analysts plainly believe Zimmer Biomet is more favorable than iRhythm Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score iRhythm Technologies 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.00Zimmer Biomet 2 Sell rating(s) 9 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.35 Do insiders and institutionals hold more shares of IRTC or ZBH? 88.9% of Zimmer Biomet shares are owned by institutional investors. 0.7% of iRhythm Technologies shares are owned by company insiders. Comparatively, 0.7% of Zimmer Biomet shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Is IRTC or ZBH more profitable? Zimmer Biomet has a net margin of 10.51% compared to iRhythm Technologies' net margin of -14.06%. Zimmer Biomet's return on equity of 12.76% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets iRhythm Technologies-14.06% -90.03% -8.52% Zimmer Biomet 10.51%12.76%7.21% Does the media favor IRTC or ZBH? In the previous week, Zimmer Biomet had 4 more articles in the media than iRhythm Technologies. MarketBeat recorded 22 mentions for Zimmer Biomet and 18 mentions for iRhythm Technologies. Zimmer Biomet's average media sentiment score of 1.66 beat iRhythm Technologies' score of 0.80 indicating that Zimmer Biomet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 9 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zimmer Biomet 21 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has better valuation and earnings, IRTC or ZBH? Zimmer Biomet has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Zimmer Biomet, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiRhythm Technologies$591.84M9.22-$113.29M-$2.93-57.95Zimmer Biomet$7.68B2.76$903.70M$4.1126.00 SummaryZimmer Biomet beats iRhythm Technologies on 12 of the 17 factors compared between the two stocks. Get iRhythm Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IRTC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRTC vs. The Competition Export to ExcelMetriciRhythm TechnologiesMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.46B$2.13B$5.74B$9.78BDividend YieldN/AN/A4.40%4.04%P/E Ratio-57.9538.0630.8326.39Price / Sales9.2247.29382.9086.63Price / CashN/A51.6137.7259.11Price / Book52.576.6310.106.62Net Income-$113.29M-$63.67M$3.26B$265.42M7 Day Performance4.04%5.03%3.90%3.58%1 Month Performance26.54%1.25%3.73%0.46%1 Year Performance149.87%27.50%37.68%19.41% iRhythm Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRTCiRhythm Technologies1.2918 of 5 stars$169.79+1.1%$162.64-4.2%+140.7%$5.46B$591.84M-57.952,000ZBHZimmer Biomet4.7569 of 5 stars$102.67-0.1%$111.44+8.5%-6.1%$20.35B$7.68B24.9817,000Positive NewsDividend AnnouncementSNNSmith & Nephew SNATS2.9734 of 5 stars$36.29+0.2%$36.00-0.8%+21.4%$15.85B$5.81B16.8017,349Positive NewsSOLVSolventum1.4851 of 5 stars$70.87-0.8%$85.75+21.0%+21.1%$12.38B$8.25B32.8122,000Positive NewsAnalyst DowngradePENPenumbra4.7531 of 5 stars$255.35+0.9%$300.47+17.7%+31.6%$9.87B$1.19B67.914,500STVNStevanato GroupN/A€22.50-0.5%N/A+9.5%€6.81B€1.19B41.675,521Positive NewsGKOSGlaukos4.7258 of 5 stars$89.47-0.4%$127.42+42.4%-29.6%$5.15B$383.48M-54.22780News CoverageAnalyst RevisionBLCOBausch + Lomb1.5692 of 5 stars$14.49-0.4%$15.56+7.4%-9.8%$5.15B$4.79B-18.5713,500TMDXTransMedics Group2.8893 of 5 stars$125.65-1.5%$123.00-2.1%-32.3%$4.35B$441.54M65.10210Positive NewsAnalyst ForecastSLNOSoleno Therapeutics4.5659 of 5 stars$68.09-4.9%$114.30+67.9%+50.9%$3.81BN/A-16.4530News CoverageAnalyst ForecastNVSTEnvista3.6925 of 5 stars$20.75+0.5%$20.92+0.9%+14.8%$3.43B$2.51B64.8312,300 Related Companies and Tools Related Companies Zimmer Biomet Alternatives Smith & Nephew SNATS Alternatives Solventum Alternatives Penumbra Alternatives Stevanato Group Alternatives Glaukos Alternatives Bausch + Lomb Alternatives TransMedics Group Alternatives Soleno Therapeutics Alternatives Envista Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRTC) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iRhythm Technologies Please log in to your account or sign up in order to add this asset to your watchlist. Share iRhythm Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access